Community Oncology Alliance
2021 Update on Targeting Pathways in Frontline CLL: BTK Resistance, Efficacy Data on BCL-2, CD20, and PI3K Inhibitors
By
2021 Community Oncology Conference
FEATURING
Jeff Sharman
By
2021 Community Oncology Conference
FEATURING
Jeff Sharman
Login to view comments.
Click here to Login